Patients with sickle cell disease (SCD) have an increased incidence of pneumococcal and Gramnegative infection ;1 2 the precise reasons for this have not been established. Opsonisation of bacteria by serum factors including complement and imnmunoglobulin is an important host defence mechanism which, in the absence of specific immunoglobulin, depends on activation of the alternative pathway of complement. Functional defects in this pathway, including factor B,3 have been associated with defective pneumococcal opsonisation4 in patients with SCD, although levels of immunochemically measured factor B are normal. 5 Opsonisation of heat-killed baker's yeast is a further test of the integrity of the alternative pathway,6 but is only partially dependent on factor B.7 Since defects are associated with an increased incidence of infection,8 we measured ability of sera from patients with SCD to opsonise yeasts, and the relation to functionally and immunochemically measured factor B and activity of the total alternative pathway of complement. The incidence of pneumococcal infection in these patients was analysed retrospectively. Patients Values given as mean i SD.
Complement studies. The mean activity of the total alternative pathway of complement in sera from patients with SCD was significantly reduced compared with controls (Table 1 ). In 25 patients and 1 control, activity was below 2 SD of the control mean.
Functional activity of factor B was also reduced (Table 1) with values in 9 patients less than 2 SD of the control mean. Sera from these 9 patients also had significant reduction in activity of total alternative pathway. There was a significant (r= 0*53, P<0.01) positive correlation between functional activities of the total alternative pathway and factor B.
Factor B was also significantly reduced when measured immunochemically (Table 1 Table 2 . The opsonisation defect in sera from patients with SCD was corrected by addition of low concentrations (0 5 %) of normal serum, normal serum depleted in factor B, or serum from patients with SCD with a factor B activity of less than half that of normal. All these sera produced similar qualitative improvement in opsonising capacity of sera from patients with primary opsonisation deficiency, but alone in a 0 5% concentration in buffer they were not opsonic ( Table 2) . Sera from patients with a primary defect of yeast opsonisation did not correct the opsonisation deficiency in sera from patients with SCD.
Relationship with pneumococcal infection. Four patients studied had recovered from pneumococcal meningitis between 2 and 11 years previously. All had reduced activity of the alternative pathway, two had a functional deficiency of factor B, and two had defective yeast opsonisation. Since the present study began, one child with deficiency of the alternative pathway and factor B has developed septic arthritis and osteomyelitis owing to Klebsiella sp.
Discussion
Inability of serum to opsonise heat-killed baker's yeast was three times more common in patients with SCD than in healthy black or white controls, in whom the incidence of deficiency was similar to that previously reported.8 10 Factor B activity is required for opsonisation of yeasts7 and was reduced, in association with total alternative pathway activity, in patients with SCD. However, low levels of factor B were not responsible for defective yeast opsonisation, since subopsonising amounts of normal sera depleted of factor B or sera from patients deficient in factor B could correct the opsonisation defect. 
